Vertex Pharmaceutic (VRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2018 | 06-2018 | 03-2018 | 12-2017 | 09-2017 | |
| Sales | 784,535 | 752,157 | 640,799 | 651,634 | 578,165 |
| Cost of Goods | 111,255 | 104,382 | 71,613 | 84,052 | 72,874 |
| Gross Profit | 673,280 | 647,775 | 569,186 | 567,582 | 505,291 |
| Operating Expenses | 467,886 | 475,279 | 440,898 | 441,897 | 832,208 |
| Operating Income | 205,649 | 172,878 | 128,901 | 125,737 | -326,043 |
| Interest Expense | 18,686 | 18,155 | 16,886 | 24,295 | 13,574 |
| Other Income | -50,452 | 61,868 | 102,627 | 11,000 | -77,553 |
| Pre-tax Income | 136,511 | 216,591 | 214,642 | 112,442 | -417,170 |
| Income Tax | 8,055 | 10,341 | -12,659 | 10,257 | -125,903 |
| Net Income Continuous | 128,456 | 206,250 | 227,301 | 102,185 | -291,267 |
| Minority Interests | -290 | -1,110 | 17,038 | 1,501 | -188,315 |
| Net Income | $128,746 | $207,360 | $210,263 | $100,684 | $-102,952 |
| EPS Basic Total Ops | 0.51 | 0.82 | 0.83 | 0.39 | -0.41 |
| EPS Basic Continuous Ops | 0.50 | 0.81 | 0.90 | 0.39 | -1.16 |
| EPS Diluted Total Ops | 0.50 | 0.80 | 0.81 | 0.39 | -0.41 |
| EPS Diluted Continuous Ops | 0.49 | 0.80 | 0.88 | 0.40 | -1.16 |
| EBITDA(a) | $224,841 | $190,937 | $145,244 | $142,169 | $-310,818 |